BIO-key International (BKYI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
8 Sep, 2026Executive summary
The annual meeting was adjourned and rescheduled to October 2, 2026, with all polls remaining open.
The meeting will be held at the company's offices in Holmdel, NJ.
The record date for voting eligibility remains July 15, 2026.
Voting matters and shareholder proposals
Stockholders who have not voted on Proposal 4 are urged to submit a new proxy using the revised proxy card or online instructions.
Those who have already voted and do not wish to change their vote need not take further action.
Shareholder rights and capital structure
Only eligible stockholders as of July 15, 2026, may vote at the rescheduled annual meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from BIO-key International
- Biometric IAM platform accelerates growth amid regulatory demand and global deployments.BKYI
Investor presentation - Shareholders will vote on director elections, auditor, compensation, and a major warrant-related share issuance.BKYI
Proxy filing - Shareholders are asked to approve warrant-related share issuance that could dilute ownership by 53.2%.BKYI
Proxy filing - Q2 2026 revenue up 13%, net loss down 51%, with record margin and EMEA-driven growth.BKYI
Q2 2026 - Biometric IAM solutions see rapid growth, regulatory tailwinds, and a path to profitability in 2026.BKYI
Investor presentation - Proxy covers director elections, auditor change, executive pay, and governance practices.BKYI
Proxy filing - Biometric authentication growth accelerates amid regulatory demand and sustained profitability.BKYI
RedChip Future Tech Investor Conference - Q1 revenue up 34% to $2.15M; profitability and Nasdaq relisting remain key near-term issues.BKYI
Q1 2026 - Q1 2025 saw sequential revenue growth, margin strength, and improved cash, but liquidity risks remain.BKYI
Q1 2025